home / stock / drug / drug news

DRUG News and Press, Bright Minds Biosciences Inc.

Stock Information
Company Name: Bright Minds Biosciences Inc.
Stock Symbol: DRUG
Market: NASDAQ
Website: brightmindsbio.com
Menu
DRUG DRUG Quote DRUG Short DRUG News DRUG Articles DRUG Message Board
Get DRUG Alerts

News, Short Squeeze, Breakout and More Instantly...
DRUG - Psychedelic stocks fall as FDA panel rejects MDMA therapy

2024-06-05 07:17:36 ET More on ATAI, COMPASS Pathways, etc. ATAI: Enormous Potential Upside But No Clarity Yet Psychedelics Closer To Commercialization; Compass Far And Away The Leader COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript Biggest stock...
DRUG - FDA advisory panel fails to endorse psychedelic MDMA therapy for PTSD

2024-06-04 17:32:04 ET More on psychedelic drug companies ATAI: Enormous Potential Upside But No Clarity Yet Psychedelics Closer To Commercialization; Compass Far And Away The Leader COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript Psychedelic sto...

DRUG - Psychedelic stocks mixed as FDA comments on MDMA therapy

2024-05-31 10:43:44 ET More on ATAI, COMPASS Pathways, etc. ATAI: Enormous Potential Upside But No Clarity Yet Psychedelics Closer To Commercialization; Compass Far And Away The Leader COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript Mind Medicine...

DRUG - DRUG Stock Earnings: Bright Minds Biosciences Reported Results for Q2 2024

2024-05-20 11:53:14 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bright Minds Biosciences (NASDAQ: DRUG ) just reported results for the second quarter of 2024. Bright Minds Biosciences reported earnings per share of -13 cents. The c...
DRUG - Psychedelic drug developers could benefit from NIH funding for chronic pain

2024-04-29 13:37:07 ET More on psychedelic drug developers Psychedelic drugs market to break $7B in 2029 led by these 3 meds Cybin spikes after FDA breakthrough tag for psychedelic therapy Psychedelic stocks gain after FDA priority review for MDMA therapy ...

DRUG - Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation

2024-03-07 11:29:12 ET More on Clearmind Medicine, Bright Minds, etc. Mind Medicine (MindMed) Inc. (MNMD) Q4 2023 Earnings Call Transcript Mind Medicine: Positive MM-120 Data Leads To Other 2024 Catalysts De-Risking Psychedelics: Compass Pathways, Cybin And Atai ...

DRUG - Psychedelic stocks gain after FDA priority review for MDMA therapy

2024-02-12 12:13:32 ET More on ATAI, COMPASS Pathways, etc. Compass Pathways: Psilocybin Developer A Potentially Intriguing, Contrarian Play Mind Medicine: Positive MM-120 Data Leads To Other 2024 Catalysts De-Risking Psychedelics: Compass Pathways, Cybin And Atai ...
DRUG - Expected US Company Earnings on Tuesday, February 6th, 2024

Algoma Steel Group Inc. (ASTL) is expected to report for Q3 2024 CTS Corporation (CTS) is expected to report for Q4 2023 Xylem Inc. New (XYL) is expected to report $0.96 for Q4 2023 TIM S.A. American Depositary Shares (Each representing 5) (TIMB) is expected to report for Q4 2023 ...

DRUG - Expected earnings - Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc. (DRUG) is expected to report for quarter end 2023-12-31

DRUG - Bright Minds Announces Non-Brokered Private Placement Fully Subscribed by Management

Bright Minds Announces Non-Brokered Private Placement Fully Subscribed by Management Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITE...
Next 10